MAK Capital Fund LP - Dec 1, 2025 SCHEDULE 13G/A Report for Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

Filing Manager
MAK Capital Fund LP
Reporting Manager
MAK Capital Fund LP
Security
Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Symbol
AUTL
Shares outstanding
266M shares
Disclosed Ownership
26.9M shares
Ownership
10.1%
Form type
SCHEDULE 13G/A
Date filed
12/3/2025, 04:04 PM
Date of event
Dec 1, 2025
Previous filing
Jun 25, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
MAK Capital Fund LP 10.1% 26.9M 0 26.9M /s/ Michael A. Kaufman Managing Member
MAK Capital One L.L.C. 10.1% 26.9M 0 26.9M /s/ Michael A. Kaufman Managing Member
Michael A. Kaufman 10.1% 26.9M 0 26.9M /s/ Michael A. Kaufman MICHAEL A. KAUFMAN